A Single Arm Phase II Study of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma After 1-3 Prior Therapies
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Carfilzomib (Primary) ; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 23 Mar 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2022.
- 23 Mar 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2019.
- 06 Jul 2016 Status changed from not yet recruiting to recruiting.